Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun biochemistry Any of a group of peptide agonists found in Gila monster venom.

Etymologies

from Wiktionary, Creative Commons Attribution/Share-Alike License

-in

Support

Help support Wordnik (and make this page ad-free) by adopting the word exendin.

Examples

  • The firm's diabetes drug is called CVX-096 and follows preclinical work on Glucagon-like peptide 1 (GLP-1) and exendin peptides.

    DrugResearcher RSS antoine.olgiati@decisionnews.com 2010

  • Amylin Pharmaceuticals 'modified exendins and exendin agonists patent: USPTO issues Final

    THE MEDICAL NEWS 2010

  • The firm's diabetes drug is called CVX-096 and follows preclinical work on Glucagon-like peptide 1 (GLP-1) and exendin peptides.

    DrugResearcher RSS antoine.olgiati@decisionnews.com 2010

  • The firm's diabetes drug is called CVX-096 and follows preclinical work on Glucagon-like peptide 1 (GLP-1) and exendin peptides.

    DrugResearcher RSS antoine.olgiati@decisionnews.com 2010

  • The firm's diabetes drug is called CVX-096 and follows preclinical work on Glucagon-like peptide 1 (GLP-1) and exendin peptides.

    DrugResearcher RSS 2010

  • The firm's diabetes drug is called CVX-096 and follows preclinical work on Glucagon-like peptide 1 (GLP-1) and exendin peptides.

    DrugResearcher RSS antoine.olgiati@decisionnews.com 2010

  • The firm's diabetes drug is called CVX-096 and follows preclinical work on Glucagon-like peptide 1 (GLP-1) and exendin peptides.

    DrugResearcher RSS 2009

  • The firm's diabetes drug is called CVX-096 and follows preclinical work on Glucagon-like peptide 1 (GLP-1) and exendin peptides.

    DrugResearcher RSS 2009

  • The firm's diabetes drug is called CVX-096 and follows preclinical work on Glucagon-like peptide 1 (GLP-1) and exendin peptides.

    DrugResearcher RSS 2009

  • The firm's diabetes drug is called CVX-096 and follows preclinical work on Glucagon-like peptide 1 (GLP-1) and exendin peptides.

    DrugResearcher RSS 2009

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.